BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29

• Drug Development

  OXIS International, Inc. Chairman And CEO Tells Shareholders Biotech Company Making ‘Substantial Progress’ With Lead Cancer Drug, Drawing Closer To NASDAQ Listing

  February 2, 2016

   · 

  7 min read
• Drug Development

  Neurocrine Biosciences Announces Initiation Of Phase II Clinical Study Of VMAT2 Inhibitor Valbenazine In Children And Adolescents With Tourette Syndrome

  February 2, 2016

   · 

  6 min read
• Business

  Luminex Reports Fourth Quarter And Full Year 2015 Results

  February 2, 2016

   · 

  2 min read
• Business

  Halozyme To Host Fourth Quarter And 2015 Year-End Financial Results Conference Call

  February 2, 2016

   · 

  2 min read
• Biotech Bay

  Sun Pharma Hopes Cut-Price Generic Gleevec Will Win Third Of U.S. Market

  February 2, 2016

   · 

  1 min read
• FDA

  Bracco Diagnostics Wins First FDA Approval for Barium-Based Product Used for Contrast Radiography

  February 2, 2016

   · 

  4 min read
• Genetown

  Spero Announces $30 Million Series B Preferred Financing

  February 2, 2016

   · 

  5 min read
• Biotech Beach

  Apricus Biosciences To Present At The 18th Annual BIO CEO & Investor Conference

  February 2, 2016

   · 

  2 min read
• BioCapital

  Lupin Launches Generic Glumetza HCI ER Tablets In The US

  February 2, 2016

   · 

  1 min read
• Biotech Beach

  Capricor Therapeutics, Inc. To Present At 18th Annual BIO CEO & Investor Conference

  February 2, 2016

   · 

  3 min read